Fieldview Capital Management, LLC Spring Works Therapeutics, Inc. Transaction History
Fieldview Capital Management, LLC
- $648 Billion
- Q4 2024
A detailed history of Fieldview Capital Management, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Fieldview Capital Management, LLC holds 31,972 shares of SWTX stock, worth $1.84 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
31,972Holding current value
$1.84 Million% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
235Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$411 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$323 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$199 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$188 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$172 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.58B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...